Former President Donald Trump announced plans on Saturday to invest $100 million in a Kentucky pharmaceutical manufacturing facility if Republicans secure victory in the upcoming Senate race. Speaking at a rally, Trump pledged that the Department of War would allocate the funds to the Antheia pharmaceutical company to revitalize a large drug production plant located in Winchester, Kentucky.
The investment offer came amid a heated Senate contest to replace retiring Sen. Mitch McConnell, a longtime Republican leader. The race has drawn significant attention as Democrats aim to capture the seat, which remains a critical battleground in the November midterm elections.
On the Democratic side, Charles Booker, a former state representative, is challenging incumbent Representative Andy Barr, a Republican who has shown a lead in recent polls. Booker’s campaign seeks to unseat Barr and flip the seat from Republican to Democrat, potentially altering the balance of power in the Senate.
Trump’s endorsement of Barr and promise of federal investment in Kentucky underscore the high stakes of the race for both parties. The proposed $100 million funding highlights an effort by Republicans to appeal to local economic interests by promising job growth and industrial revitalization, should Republicans retain control of the seat.
Officials from Antheia and federal agencies have yet to confirm specifics regarding the potential investment. The Department of War, as referenced by Trump in his remarks, is not a current federal entity, leading to questions about the mechanism and formal status of the proposed funding.
As the November election approaches, both campaigns continue to campaign vigorously across Kentucky, emphasizing economic development and healthcare as key issues for voters in the state.